Clinical translation of "A diabetes outcome progression trial":: ADOPT appropriate combination oral therapies in type 2 diabetes

被引：24

作者：

Goldstein, Barry J. ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Jefferson Med Col, Dept Med, Div Endocrinol & Metab Dis, Philadelphia, PA 19107 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2007年 / 92卷 / 04期

关键词：

D O I：

10.1210/jc.2006-2858

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：1226 / 1228

页数：3

共 21 条

[1]

*AM COLL END, 2002, ENDOCR PRACT S1, V8, P5

[2]

[Anonymous], 2007, DIABETES CARE, DOI DOI 10.2337/DC07-S004

[3]

Earlier intervention in type 2 diabetes: The case for achieving early and sustained glycaemic control [J].

Bailey, CJ ;

Del Prato, S ;

Eddy, D ;

Zinman, B .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (11) :1309-1316

[4]

Cheng AYY., 2003, CAN J DIABETES, V27

[5]

Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes [J].

Garber, AJ ;

Donovan, DS ;

Dandona, P ;

Bruce, S ;

Park, JS .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3598-3604

[6]

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].

Gerstein, H. C. ;

Yusuf, S. ;

Holman, R. R. ;

Bosch, J. ;

Anand, S. ;

Avezum, A. ;

Budaj, A. ;

Chiasson, J. ;

Conget, I. ;

Dagenais, G. ;

Davis, M. ;

Diaz, R. ;

Dinccag, N. ;

Enjalbert, M. ;

Escalante, A. ;

Fodor, G. ;

Hanefeld, M. ;

Hedner, T. ;

Jolly, K. ;

Keltai, M. ;

Laakso, M. ;

Lanas, F. ;

Lonn, E. ;

McQueen, M. ;

Mohan, V. ;

Phillips, A. ;

Piegas, L. ;

Pirags, V. ;

Probstfield, J. ;

Shaw, J. ;

Schmid, I. ;

Teo, K. ;

Zimmet, P. ;

Zinman, B. ;

Gerstein, H. C. ;

Yusuf, S. ;

Bosch, J. ;

Pogue, J. ;

Sheridan, P. ;

Dinccag, N. ;

Hanefeld, M. ;

Hoogwerf, B. ;

Laakso, M. ;

Mohan, V. ;

Shaw, J. ;

Zinman, B. ;

Holman, R. R. ;

Diaz, R. ;

Ahuad Guerrero, R. ;

Albisu, J. .

LANCET, 2006, 368 (9541) :1096-1105

[7]

Management of hyperglycaemia in type 2 diabetes [J].

Heine, R. J. ;

Diamant, M. ;

Mbanya, J-C ;

Nathan, D. M. .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7580) :1200-1204A

[8]

Oral antihyperglycemic therapy for type 2 diabetes - Scientific review [J].

Inzucchi, SE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :360-372

[9]

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].

Kahn, Steven E. ;

Haffner, Steven M. ;

Heise, Mark A. ;

Herman, William H. ;

Holman, Rury R. ;

Jones, Nigel P. ;

Kravitz, Barbara G. ;

Lachin, John M. ;

O'Neill, M. Colleen ;

Zinman, Bernard ;

Viberti, Giancarlo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443

[10]

McCall AL, 2003, TXB TYPE 2 DIABETES, P155

← 1 2 3 →